Introduction
We routinely manage safety pharmacology studies, generally as part of “first-in-man” non-clinical programmes. These studies are not conducted in-house but are sub-contracted to a partner organisation with specialist experience in this area.
Examples of models/methods established for the assessment of primary and secondary functions or safety of new drug candidates.
- Primary pharmacology
- Proof of concept
- Disease models
- Early safety pharmacology
- ICH S7A Core battery